Breaking News Instant updates and real-time market news.

EFX

Equifax

$115.18

-0.7807 (-0.67%)

09:59
09/13/17
09/13
09:59
09/13/17
09:59

Technical View: Equifax falls to session lows, 52-week low in view

Shares were last at $112.48, down 3% on the day. At that price next support is the 52-week low at $110.87. Resistance is at $114.04.

EFX Equifax
$115.18

-0.7807 (-0.67%)

09/08/17
MACQ
09/08/17
NO CHANGE
MACQ
Beneficiaries of Equifax data breach at Macquarie
Macquarie analyst Sarah Hindlian said key beneficiaries of the Equifax (EFX) data breach are Proofpoint (PFPT) with its leading messaging solutions, Symantec (SYMC) which offers consumer identity theft services, and Imperva (IMPV) which offers web application security solutions.
09/11/17
PIPR
09/11/17
NO CHANGE
PIPR
Piper sees Equifax breach as positive for Symantec, FireEye, Proofpoint
Piper Jaffray analyst Andrew Nowinski views Equifax's (EFX) a cybersecurity breach as positive for Symantec (SYMC), FireEye (FEYE) and Proofpoint (PFPT). "Mega-breaches like Equifax not only create awareness for the security space, but typically result in an increase in spending by enterprises," Nowinski tells investors in a research note. Equifax offers a number of credit monitoring and identity theft protection services, similar to Symantec's LifeLock, the analyst points out. He believes Symantec should see a benefit to its LifeLock business. Nowinski adds FireEye's Mandiant has been reported to have been contracted to investigate the breach. The analyst's top picks remain Proofpoint and Symantec.
09/11/17
EVER
09/11/17
NO CHANGE
Target $174
EVER
Outperform
Equifax weakness a buying opportunity, says Evercore ISI
Evercore ISI analyst David Togut defended Equifax again after the second day of weakness due to the data breach. Togut said said there no new negative fundamental developments that would pressure the long-term earnings power of the company and reiterated his Outperform rating and $174 price target.
09/12/17
BARD
09/12/17
NO CHANGE
Target $141
BARD
Outperform
Equifax pullback on data breach an overreaction, says Baird
Baird analyst Jeffrey Meuler said although the Equifax data breach remains a notable negative, he views the selloff as an overreaction. He continues to believe the company's access to key data sources are unlikely to be affected and client relationships are unlikely to be meaningfully impaired in the intermediate to long-term. Meuler reiterated his Outperform rating and $141 price target on Equifax shares.

TODAY'S FREE FLY STORIES

CUB

Cubic

$51.60

4.8 (10.26%)

07:27
09/25/17
09/25
07:27
09/25/17
07:27
Recommendations
Cubic analyst commentary  »

Cubic price target raised…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GLW

Corning

$30.05

-0.05 (-0.17%)

07:26
09/25/17
09/25
07:26
09/25/17
07:26
Periodicals
Corning looks to expand Gorilla presence in auto glass market, DigiTimes says »

Corning is looking to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

07:26
09/25/17
09/25
07:26
09/25/17
07:26
General news
Futures pointing to slightly lower open »

Stock futures are trading…

ALSSF

Alsea

$3.53

-0.1382 (-3.77%)

07:25
09/25/17
09/25
07:25
09/25/17
07:25
Upgrade
Alsea rating change  »

Alsea upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

STAA

STAAR Surgical

$10.90

0.05 (0.46%)

07:24
09/25/17
09/25
07:24
09/25/17
07:24
Upgrade
STAAR Surgical rating change  »

STAAR Surgical upgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RIG

Transocean

$9.32

0.24 (2.64%)

07:24
09/25/17
09/25
07:24
09/25/17
07:24
Technical Analysis
Technical View: Transocean trades higher in pre-market, analyst action »

The shares were last up…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

  • 27

    Sep

  • 02

    Oct

ZG

Zillow

$38.93

-0.93 (-2.33%)

07:23
09/25/17
09/25
07:23
09/25/17
07:23
Initiation
Zillow initiated  »

Zillow initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Oct

AMAT

Applied Materials

07:23
09/25/17
09/25
07:23
09/25/17
07:23
Recommendations
Applied Materials analyst commentary  »

Applied Materials analyst…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Sep

AEM

Agnico Eagle

$46.74

0.6 (1.30%)

07:23
09/25/17
09/25
07:23
09/25/17
07:23
Recommendations
Agnico Eagle analyst commentary  »

Agnico Eagle price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Oct

DK

Delek US

$25.70

0.25 (0.98%)

07:22
09/25/17
09/25
07:22
09/25/17
07:22
Conference/Events
Delek US management to meet with Deutsche Bank »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

  • 27

    Sep

APOP

Cellect Biotechnology

$8.28

0.19 (2.35%)

07:22
09/25/17
09/25
07:22
09/25/17
07:22
Recommendations
Cellect Biotechnology analyst commentary  »

Cellect Biotechnology…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LPX

Louisiana-Pacific

$28.44

0.53 (1.90%)

07:21
09/25/17
09/25
07:21
09/25/17
07:21
Recommendations
Louisiana-Pacific analyst commentary  »

Louisiana-Pacific price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CTSO

CytoSorbents

07:20
09/25/17
09/25
07:20
09/25/17
07:20
Hot Stocks
CytoSorbents highlights publication of study in Journal of Artificial Organs »

CytoSorbents highlighted…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CRMD

CorMedix

$0.47

0.048 (11.37%)

07:20
09/25/17
09/25
07:20
09/25/17
07:20
Recommendations
CorMedix analyst commentary  »

CorMedix price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

07:20
09/25/17
09/25
07:20
09/25/17
07:20
General news
FX Update: The euro has come under across-the-board pressure »

FX Update: The euro has…

TWTR

Twitter

$17.61

0.03 (0.17%)

07:19
09/25/17
09/25
07:19
09/25/17
07:19
Periodicals
Twitter tests Twitter Lite Android app in the Philippines, TechCrunch says »

Twitter is testing an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NBLX

Noble Midstream

$50.36

-0.13 (-0.26%)

, NBL

Noble Energy

$27.02

0.07 (0.26%)

07:18
09/25/17
09/25
07:18
09/25/17
07:18
Hot Stocks
Noble Midstream now sees Q3 net income $42M-$43M »

Noble Midstream Partners…

NBLX

Noble Midstream

$50.36

-0.13 (-0.26%)

NBL

Noble Energy

$27.02

0.07 (0.26%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

  • 27

    Sep

  • 03

    Oct

  • 31

    Oct

NOC

Northrop Grumman

$281.55

1.13 (0.40%)

07:17
09/25/17
09/25
07:17
09/25/17
07:17
Hot Stocks
Northrop Grumman announces support contract for U.K. CUTLASS vehicles »

Northrop Grumman…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WBC

Wabco

$150.14

0.95 (0.64%)

07:17
09/25/17
09/25
07:17
09/25/17
07:17
Recommendations
Wabco analyst commentary  »

Wabco price target raised…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Oct

CSIQ

Canadian Solar

$16.46

0.6 (3.78%)

07:16
09/25/17
09/25
07:16
09/25/17
07:16
Hot Stocks
Tokyo Stock Exchange approves listing of Canadian Solar Infrastructure Fund »

Canadian Solar announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

KMX

CarMax

$74.19

5.35 (7.77%)

07:16
09/25/17
09/25
07:16
09/25/17
07:16
Downgrade
CarMax rating change  »

CarMax downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ALXN

Alexion

$142.82

-0.1 (-0.07%)

07:16
09/25/17
09/25
07:16
09/25/17
07:16
Recommendations
Alexion analyst commentary  »

Alexion Soliris to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Sep

  • 23

    Oct

SGYP

Synergy Pharmaceuticals

$2.59

-0.05 (-1.89%)

07:15
09/25/17
09/25
07:15
09/25/17
07:15
Recommendations
Synergy Pharmaceuticals analyst commentary  »

Synergy Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

  • 26

    Sep

  • 24

    Jan

OB

Onebeacon Insurance

$18.11

0.01 (0.06%)

07:14
09/25/17
09/25
07:14
09/25/17
07:14
Hot Stocks
All regulatory approvals obtained for Intact Financial's acquisition of Onebeacon Insurance »

OneBeacon Insurance Group…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

XHR

Xenia Hotels & Resorts

$20.85

0.25 (1.21%)

07:13
09/25/17
09/25
07:13
09/25/17
07:13
Hot Stocks
Xenia Hotels & Resorts provides update on Hyatt Centric Key West Resort & Spa »

Xenia Hotels &…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    Nov

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.